SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-20-121027
Filing Date
2020-11-03
Accepted
2020-11-03 17:21:50
Documents
2
Period of Report
2020-12-09
Effectiveness Date
2020-11-03

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm2034104d2_def14a.htm DEF 14A 574607
2 GRAPHIC tm2034104d2_def14aimg001.jpg GRAPHIC 8031
  Complete submission text file 0001104659-20-121027.txt   587060
Mailing Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737
Business Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737 302 355-0650
iBio, Inc. (Filer) CIK: 0001420720 (see all company filings)

IRS No.: 262797813 | State of Incorp.: DE | Fiscal Year End: 0630
Type: DEF 14A | Act: 34 | File No.: 001-35023 | Film No.: 201284443
SIC: 2834 Pharmaceutical Preparations